Squaraine dye based prostate-specific membrane antigen probes for near-infrared fluorescence imaging of prostate cancer

被引:3
|
作者
Chen, Yimin [1 ]
Li, Yuying [1 ]
Gao, Xi [1 ]
Cui, Mengchao [1 ,2 ]
机构
[1] Beijing Normal Univ, Coll Chem, Key Lab Radiopharmaceut, Minist Educ, Beijing 100875, Peoples R China
[2] Beijing Normal Univ Zhuhai, Ctr Adv Mat Res, Zhuhai 519087, Peoples R China
基金
中国国家自然科学基金;
关键词
ANDROGEN-DEPRIVATION THERAPY; POSITIVE SURGICAL MARGINS; RADICAL PROSTATECTOMY; PSMA LIGANDS; SURGERY; AGENTS; ACID;
D O I
10.1016/j.dyepig.2022.110822
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Prostate cancer (PCa) is the most common cancer-related malignancy in older men worldwide, with a high mortality rate. To solve the problems of positive margins and other complications during radical prostatectomy, it is currently necessary to develop suitable optical imaging probes to distinguish tumor from normal tissue during surgery. Prostate-specific membrane antigen (PSMA) is a membrane-bound glutamate carboxypeptidase II (GCP II) overexpressed in PCa. In this article, a new squaraine dye based probe (SQ-CN-PSMA) for PSMA has been developed, displaying suitable optical properties (lambda(EM) = 706 nm, Phi = 23%), ideal water solubility and high affinity (K-i = 0.34 nM). In vivo optical imaging in 22Rv1 xenografts in Balb/c nude mice demonstrated good visualization of PSMA-expressing tumors with higher TNR value (11.08 +/- 1.59 for 24 h) at a low dosage (2 nmol). Overall, SQ-CN-PSMA holds great potential for imaging PSMA tumors and could be used in assisting surgeons performing prostatectomies for the treatment of PCa.
引用
下载
收藏
页数:8
相关论文
共 50 条
  • [31] Prostate-specific membrane antigen (PSMA)-based diagnostics and treatment of prostate cancer
    Afshar-Oromieh, A.
    Alberts, I.
    Sachpekidis, C.
    Rominger, A.
    UROLOGE, 2019, 58 (12): : 1429 - 1434
  • [32] Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy
    Wuestemann, Till
    Haberkorn, Uwe
    Babich, John
    Mier, Walter
    MEDICINAL RESEARCH REVIEWS, 2019, 39 (01) : 40 - 69
  • [33] Re: Prostate-Specific Membrane Antigen PET in Prostate Cancer
    Siegel, Cary
    JOURNAL OF UROLOGY, 2021, 206 (04): : 1044 - 1044
  • [34] Advances in prostate-specific membrane antigen PET of prostate cancer
    Bouchelouche, Kirsten
    Choyke, Peter L.
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (03) : 189 - 196
  • [35] Updates of prostate cancer staging: Prostate-specific membrane antigen
    Sathianathen, Niranjan J.
    Lamb, Alastair
    Nair, Rajesh
    Geurts, Nicolas
    Mitchell, Catherine
    Lawrentschuk, Nathan L.
    Moon, Daniel A.
    Murphy, Declan G.
    INVESTIGATIVE AND CLINICAL UROLOGY, 2016, 57 : S147 - S154
  • [36] Targeting the prostate-specific membrane antigen for prostate cancer therapy
    Buehler, Patrick
    Wolf, Philipp
    Elsaesser-Beile, Ursula
    IMMUNOTHERAPY, 2009, 1 (03) : 471 - 481
  • [37] Prostate-specific antigen and prostate cancer
    Rosalki, SB
    Rutherford, FJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (09) : 611 - 613
  • [38] Prostate-specific membrane antigen
    Maraj, BH
    Whelan, P
    Markham, AF
    BRITISH JOURNAL OF UROLOGY, 1998, 81 (04): : 523 - 528
  • [39] Prostate-specific membrane antigen
    Fair, WR
    Israeli, RS
    Heston, WDW
    PROSTATE, 1997, 32 (02): : 140 - 148
  • [40] PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen
    Elsaesser-Beile, Ursula
    Reischl, Gerald
    Wiehr, Stefan
    Buehler, Patrick
    Wolf, Philipp
    Alt, Karen
    Shively, John
    Judenhofer, Martin S.
    Machulla, Hans-Juergen
    Pichler, Bernd J.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (04) : 606 - 611